Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724287 | SCV000226528 | pathogenic | not provided | 2014-09-23 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV003231356 | SCV000782184 | pathogenic | Sotos syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763136 | SCV000893696 | pathogenic | Acute myeloid leukemia; Sotos syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724287 | SCV001500865 | pathogenic | not provided | 2020-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003231356 | SCV001588171 | pathogenic | Sotos syndrome | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003231356 | SCV002054950 | pathogenic | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
3billion | RCV003231356 | SCV002059110 | pathogenic | Sotos syndrome | 2022-01-03 | criteria provided, single submitter | clinical testing | The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000194672, PMID:12464997). Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Centre de Biologie Pathologie Génétique, |
RCV002273973 | SCV002559012 | pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV003231356 | SCV003824210 | pathogenic | Sotos syndrome | 2022-12-21 | criteria provided, single submitter | clinical testing |